The Most Popular Skincare Ingredients in Singapore - What the Research Actually Says
A research-based guide to 20+ skincare ingredients popular in Singapore and across K-beauty, J-beauty, and Western markets: what the evidence supports, what is overhyped, and what is restricted or unavailable as a cosmetic in Singapore.

Skincare has always had a marketing problem. Ingredients get named, amplified, and sold before the evidence catches up. At the same time, some genuinely well-researched ingredients get drowned out by the noise.
This guide covers the ingredients most commonly found in skincare sold across Singapore, Korea, Japan, and Western markets - what each one actually does, how strong the evidence is, and where limits exist. The goal is not to rank them but to give you a clear enough picture to evaluate any product you are considering.

How to read skincare research
A few terms worth knowing before getting into ingredients.
In vitro means the research was done on cells in a lab, not on human skin. It can suggest a mechanism but does not confirm it works in a real product on real skin.
In vivo means tested on living skin, either on animals or on humans. Human in vivo evidence is the most relevant.
A randomised controlled trial (RCT) is the gold standard for clinical evidence. Most skincare ingredients have far fewer RCTs than pharmaceutical drugs, and the trials that do exist are often small, short, or sponsored by brands.
Clinically proven on a label means almost nothing without knowing what study it refers to. A 4-week trial with 20 participants using a brand-funded outcome measure is technically a clinical study.
With that in mind, here is where the main ingredients stand.

Ingredients with strong evidence
Retinoids (retinol, retinal, tretinoin)
Retinoids are vitamin A derivatives and represent the most extensively studied anti-ageing and skin-renewing category in skincare. They work by binding to nuclear receptors and influencing gene expression, speeding up cell turnover, stimulating collagen production, and reducing melanin clustering.
Tretinoin (retinoic acid) is the prescription-strength form and has the most clinical evidence behind it, including decades of RCT data for acne, wrinkles, and photodamage. It is a prescription-only medicine in Singapore and cannot legally be included in cosmetic products sold over the counter.
Retinol is the most common OTC form. It converts to retinoic acid in the skin, so it works by the same mechanism but more slowly and with less irritation risk. Evidence at concentrations of 0.025% to 1% is solid for texture improvement, tone, and fine lines. Retinal (retinaldehyde) sits between the two in potency and has growing evidence as a more efficient converter than retinol with less irritation than tretinoin.
Starter concentrations of 0.025% to 0.1% are appropriate for new users. Building tolerance before increasing concentration matters more than starting high.
Niacinamide (vitamin B3)
One of the most well-studied cosmetic ingredients currently available. Niacinamide works across multiple pathways: it inhibits melanosome transfer (reducing dark spots), upregulates ceramide and fatty acid production (supporting the skin barrier), reduces sebum production at higher concentrations, and has anti-inflammatory properties useful in acne and redness-prone skin.
Clinical trials have shown 5% niacinamide reduces hyperpigmentation meaningfully within four weeks. It is pH-flexible, stable, and combines well with most other actives. The old concern about it reacting with vitamin C to form nicotinic acid (causing flushing) has been largely disproven at typical skincare concentrations - that reaction requires prolonged heat exposure.
Evidence level: strong. One of the few ingredients with consistent RCT support across multiple skin concerns.
Vitamin C (L-ascorbic acid and derivatives)
Vitamin C is an antioxidant that also inhibits tyrosinase (the enzyme that drives melanin production) and plays a role in collagen synthesis. The evidence for brightening and antioxidant protection is well-established.
The challenge is delivery. L-ascorbic acid (LAA) is the most potent and bioactive form but is highly unstable - it oxidises rapidly when exposed to light, air, and heat. An oxidised vitamin C product (which turns orange or brown) has lost most of its efficacy. LAA also requires a low pH (below 3.5) to penetrate the skin effectively, which can be irritating.
Derivatives offer trade-offs. Ascorbyl glucoside is stable and converts to active vitamin C in the skin, with moderate evidence for efficacy. Magnesium ascorbyl phosphate (MAP) and sodium ascorbyl phosphate (SAP) are water-soluble, gentler, and better suited to sensitive skin. Ascorbyl tetraisopalmitate is oil-soluble with good skin penetration and growing evidence. No derivative fully matches LAA in potency but most are more practical to formulate stably.
For vitamin C products, dark glass or airtight packaging matters. Avoid products in clear bottles or with pump tops that let in air.
AHA (alpha hydroxy acids)
Alpha hydroxy acids - primarily glycolic acid, lactic acid, and mandelic acid - are water-soluble exfoliants that work by loosening the bonds between dead skin cells, allowing them to shed more evenly.
Glycolic acid has the smallest molecule and deepest penetration, with strong evidence for texture, brightness, and fine lines. Lactic acid is larger, penetrates more slowly, and is better tolerated by sensitive skin. Mandelic acid is the gentlest, with antibacterial properties that make it useful in acne-prone skin.
AHAs increase photosensitivity, making daily SPF use essential. Concentrations above 10% at low pH are more aggressive and require care to avoid barrier disruption. Most OTC products sit at 5-10%, which is effective for maintenance use.
Evidence level: strong for glycolic and lactic acids specifically.
BHA (salicylic acid)
Salicylic acid is oil-soluble, which allows it to penetrate into the pore lining - something AHAs cannot do. This makes it the exfoliant of choice for oily, congested, and acne-prone skin. It also has anti-inflammatory and mild antibacterial properties.
Effective concentrations are typically 0.5-2% in leave-on products. It is well-tolerated by most skin types, though drying for some at higher concentrations.
Evidence level: strong for acne and congestion. One of the few cosmetic actives with decades of dermatological use behind it.
Tranexamic acid
Originally used as an oral medication to prevent excessive bleeding, tranexamic acid has emerged as one of the most effective cosmetic ingredients for hyperpigmentation. It works by inhibiting plasmin-induced melanocyte activation - a different mechanism to most brightening ingredients, which makes it effective in combination with niacinamide, vitamin C, or azelaic acid.
Topical concentrations of 2-5% in clinical studies have shown significant reduction in melasma and post-inflammatory hyperpigmentation (PIH). A 2024 study found a combination of tranexamic acid, niacinamide, and vitamin C reduced MASI scores (a melasma severity measure) by 63%.
Evidence level: moderate to strong, with a growing RCT base particularly for melasma.
Azelaic acid
A naturally occurring dicarboxylic acid found in grains like barley and rye. It works through multiple pathways: tyrosinase inhibition (brightening), anti-inflammatory action, and antibacterial activity against P. acnes.
Azelaic acid is particularly well-suited to sensitive, redness-prone, and rosacea-affected skin. It is one of the few brightening ingredients considered safe during pregnancy. At 15-20% concentration it is prescription-grade in some markets, though 10% is widely available OTC and shows meaningful efficacy.
Evidence level: strong for rosacea and moderate for hyperpigmentation.
Ingredients with moderate evidence
Ceramides
Ceramides are lipids that make up roughly 50% of the outer skin barrier. Topical ceramides help replenish and support barrier function - particularly relevant for eczema-prone, dry, and sensitive skin types, and for anyone using aggressive actives that can disrupt the barrier.
The clinical evidence is solid for barrier support and reduction of transepidermal water loss (TEWL), though the precise formulation ratio matters. Products combining ceramides with cholesterol and fatty acids in a physiological ratio show the best results.
Evidence level: moderate to strong for barrier repair.
Peptides
Peptides are short chains of amino acids that signal the skin to produce collagen, elastin, or other proteins. The category is broad and the evidence is highly variable depending on the specific peptide.
Matrixyl (palmitoyl pentapeptide-4) has reasonable evidence for collagen stimulation. Argireline (acetyl hexapeptide-3) is marketed as a botox alternative with some evidence for reducing expression lines, though the mechanism and magnitude are debated. Copper peptides (GHK-Cu) have evidence for wound healing and collagen synthesis, with growing interest in skin renewal.
The challenge with peptides is that many are too large to penetrate the skin barrier effectively in standard formulations. Delivery system matters enormously.
Evidence level: variable by peptide. Some (Matrixyl, GHK-Cu) have reasonable human data; others have mostly in vitro evidence.
Centella Asiatica (cica)
An herb used in traditional medicine across Asia, centella contains active compounds including asiaticoside, madecassoside, and asiatic acid. These have anti-inflammatory, wound-healing, and barrier-supporting properties.
Evidence is strongest for wound healing and barrier repair. The soothing claims are well-supported. Anti-ageing claims are less established.
Evidence level: moderate for barrier support and inflammation; weaker for anti-ageing.
Snail mucin (snail secretion filtrate)
A K-beauty staple, snail mucin is rich in glycoproteins, hyaluronic acid, glycolic acid, and growth factors. Clinical and preclinical evidence suggests benefits for wound healing, hydration, and skin regeneration.
A 2025 NIH-published review confirmed wound healing, anti-inflammatory, and antibacterial properties, with the glycoproteins playing a key role in collagen stimulation. However, most clinical trials are small and short. It is a well-tolerated, multifunctional humectant and barrier ingredient rather than a targeted active.
Evidence level: moderate for hydration and healing; limited for specific anti-ageing claims.
Alpha arbutin
Alpha arbutin is a stable, synthetic derivative of hydroquinone that inhibits tyrosinase without the safety concerns associated with hydroquinone itself. It is well-tolerated across skin tones and has a growing body of evidence for hyperpigmentation reduction.
A 2025 Journal of Cosmetic Dermatology study compared alpha-arbutin 5% and kojic acid 2% against triple combination cream (the clinical gold standard for melasma) and found comparable outcomes with fewer adverse events and lower recurrence rates.
Evidence level: moderate to strong. One of the cleaner brightening options available OTC.
Kojic acid
A byproduct of rice fermentation commonly used in Japanese and Korean brightening products, kojic acid inhibits tyrosinase and has a reasonable evidence base for dark spots and melasma.
Its main limitation is stability - kojic acid oxidises on exposure to air and light, reducing efficacy. It can also cause sensitisation in some users with prolonged use. Derivatives like kojic acid dipalmitate are more stable but less studied.
Evidence level: moderate. Effective but formulation quality matters significantly.
Beta-glucan
Derived from oats, yeast, or mushrooms, beta-glucan is a polysaccharide with strong evidence for immune modulation, wound healing, and skin hydration. In skincare, it functions as a potent humectant and anti-inflammatory agent, forming a film that reduces TEWL and soothes reactive skin.
Evidence for direct anti-ageing effects is more limited, but as a barrier-supporting and soothing ingredient it is one of the better-evidenced options in its category. Search interest has grown significantly in 2025 as consumers look for alternatives to hyaluronic acid.
Evidence level: moderate to strong for hydration and soothing.
Polyglutamic acid (PGA)
A fermentation-derived humectant originally developed in Japan. PGA can hold significantly more moisture than hyaluronic acid and, uniquely, inhibits hyaluronidase - the enzyme that breaks down hyaluronic acid in the skin. This makes it both a surface humectant and a preserver of internal hydration.
Evidence is growing but still primarily in vitro and small-scale in vivo. It is well-formulated into many Japanese serums and essences.
Evidence level: emerging. Mechanistic evidence is promising; larger human trials are limited.
Hyaluronic acid (HA)
One of the most widely used humectants in skincare. HA is a naturally occurring polysaccharide that binds water, making it a staple for hydration. However, molecule size matters significantly. High molecular weight HA stays on the skin surface and reduces TEWL. Low molecular weight HA can penetrate more deeply but there is debate about whether deep penetration improves outcomes or causes mild inflammation.
Multi-weight formulas attempt to address both. HA is non-irritating, well-tolerated across skin types, and safe. It is a reliable humectant rather than a transformative active.
Evidence level: strong for surface hydration; more nuanced for deeper penetration claims.
Ingredients with emerging or limited evidence
PDRN (polydeoxyribonucleotide)
Originally used in medical settings for wound healing and tissue repair, PDRN is derived from salmon DNA and activates adenosine receptors linked to cell regeneration and collagen production. A dominant K-beauty trend for 2025-2026.
Clinical evidence exists primarily from in-clinic use - injections and post-procedure recovery - where results have been documented. Topical OTC evidence is significantly thinner. The molecule is large and skin penetration of intact PDRN through the stratum corneum is uncertain without physical disruption such as microneedling or laser.
Consumer serums containing PDRN are available and widely sold. Evidence for meaningful topical benefit without clinical procedures remains limited.
Evidence level: strong in clinical and injectable settings; limited for standard topical OTC use.
Exosomes
Exosomes are extracellular vesicles that carry proteins, lipids, and genetic material between cells, playing a role in cell signalling. In clinical aesthetics, exosome treatments used after laser or microneedling have shown promising results for regeneration and recovery.
For topical consumer use, the regulatory and evidence picture is still developing. In Singapore, exosome products sold as cosmetics are held to cosmetic claim standards and approved for topical use only - direct injection is not an approved cosmetic practice. Consumer-level efficacy data for intact topical exosomes remains limited, and claims should be read carefully.
Evidence level: promising in clinical settings; consumer-level topical evidence is early-stage.
EGF (epidermal growth factor)
EGF is a protein that stimulates cell proliferation and is used in medical wound healing. Its appeal in skincare is the theoretical link between cell signalling and skin renewal.
The practical limitation is significant: EGF molecules exceed 500 Daltons, which is the threshold above which absorption through intact skin becomes increasingly difficult. Without delivery enhancement such as liposomes, or after clinical procedures that disrupt the barrier, evidence for topical benefit in standard OTC formats is limited.
Evidence level: limited for standard topical use. Better evidence exists in post-procedure and clinical contexts.
Bakuchiol
A plant-derived compound from the babchi plant, often marketed as a retinol alternative. Research shows bakuchiol activates some of the same cellular pathways as retinol and has additional effects on fibronectin production and wound healing.
A 2019 study comparing 0.5% bakuchiol to 0.5% retinol twice daily found comparable improvements in wrinkles, pigmentation, and firmness with less irritation. It is a legitimate and well-tolerated option for people who cannot use retinol, but it is not equivalent in potency and long-term evidence is still building.
Evidence level: moderate. A good alternative for retinol-intolerant users; not a direct replacement.
Sea kelp bioferment
A fermented extract derived from kelp using Lactobacillus. Fermentation increases bioavailability of kelp naturally occurring compounds - amino acids, antioxidants, and minerals. It functions primarily as a humectant and soothing ingredient with some antioxidant activity.
Evidence is largely in vitro and formulation-level. A pleasant, well-tolerated ingredient found in many J-beauty and clean beauty products, but evidence for specific skin outcomes at typical use concentrations is limited.
Evidence level: emerging. More ingredient profile than targeted active.
NMN (nicotinamide mononucleotide)
NMN is a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme central to cellular energy metabolism and DNA repair. NAD+ levels decline with age, and restoring them is one of the more credible mechanisms being explored in longevity research.
For topical use, recent research is more promising than most emerging ingredients in this category. A 2025 study found that applying NMN solution to the stratum corneum resulted in a 100-fold increase in intracellular NMN and approximately a four-fold rise in NAD+ in skin cells. Separately, NMN was found to inhibit melanin production in aged melanocytes by downregulating cAMP/Wnt signalling pathways, suggesting a brightening mechanism distinct from tyrosinase inhibition.
However, the key limitation remains: no large-scale human clinical trials have yet confirmed meaningful anti-ageing or brightening effects from topical NMN in standard cosmetic formulations. Most evidence is in vitro or early-stage in vivo. The oral supplement research (which is more developed) does not directly translate to topical efficacy.
NMN is permitted in cosmetic products in Singapore. The ingredient is attracting serious research attention and is worth monitoring, but at this stage the consumer evidence has not caught up with the mechanistic promise.
Evidence level: early but scientifically grounded. More credible than most emerging longevity ingredients; human trial data still limited.
Spermidine
A polyamine compound involved in autophagy - the cellular clean-up process. Growing research interest in oral spermidine for longevity has extended into topical skincare applications.
Early in vitro evidence suggests potential for hair growth stimulation and cellular renewal. Human clinical evidence for topical skin use is very limited as of 2026. Worth watching but not yet ready to form the basis of a routine decision.
Evidence level: very early. Interesting mechanistic research; insufficient human data to draw practical conclusions.

Tools and procedures: microneedling and LED therapy
Beyond ingredients, a growing category of at-home tools has entered the market. Two in particular are worth understanding.
Microneedling and dermarollers
Microneedling uses fine needles to create micro-channels in the skin, triggering a wound-healing response that stimulates collagen production. In clinical settings - with professional devices at appropriate needle depths - the evidence for texture improvement, scar reduction, and product absorption is solid.
At-home dermarollers are a different matter. Consumer devices typically use shorter needles (0.2-0.5mm) which reach only the epidermis rather than the dermis where collagen production occurs. The clinical benefit at these depths is limited compared to professional treatment.
The more significant concern is misuse. Rolling over active acne, broken skin, or inflamed areas can worsen conditions and spread bacteria. Using a dermaroller immediately before applying active ingredients, particularly retinoids, exfoliating acids, or strong vitamin C, can increase irritation instead of improving results.
Home devices also create hygiene questions. Needles that are not sterile, reused too often, or stored badly can introduce bacteria into compromised skin. For most everyday users, the risk-benefit balance is not strong enough to make at-home dermarolling a routine essential.
Evidence level: strong for professional microneedling in appropriate settings; limited and higher-risk for casual at-home dermarollers.
LED therapy
LED devices use specific wavelengths of light to influence skin biology. Red light is commonly used for inflammation support and collagen-related claims. Blue light targets acne-related bacteria. In-clinic devices are usually stronger and more consistent than many consumer masks.
The evidence is moderate for acne support with blue light and emerging-to-moderate for red light used consistently. Results depend heavily on device quality, wavelength, power output, distance from skin, and repeated use over time.
The practical limitation is compliance. A device only helps if it is used regularly and safely. It should not replace sunscreen, acne treatment, barrier repair, or medical advice when symptoms are significant.
Evidence level: moderate for selected uses, but device quality and consistency matter.
Bottom line
The best-evidenced skincare categories remain familiar: retinoids, sunscreen, niacinamide, vitamin C, AHAs, BHAs, azelaic acid, tranexamic acid, ceramides, and proven barrier-supporting ingredients. Newer trends can be interesting, but they should earn their place in a routine rather than replace the basics.
For Singapore routines, evidence is only one part of the decision. Stability in heat, tolerance in humid weather, compatibility with daily sunscreen, and realistic long-term use matter just as much as the ingredient name on the front of the bottle.


